Published in Br J Psychiatry on January 01, 2010
Molecular imaging in patients with mood disorders: a review of PET findings. Eur J Nucl Med Mol Imaging (2011) 0.81
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg (2011) 3.30
An adaptive reflexive processing model of neurocognitive function: supporting evidence from a large scale (n = 100) fMRI study of an auditory oddball task. Neuroimage (2005) 2.60
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain (2005) 2.40
PET performance measurements using the NEMA NU 2-2001 standard. J Nucl Med (2002) 2.06
Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. J Child Psychol Psychiatry (2010) 2.05
Calcein labelling and electrophysiology: insights on coral tissue permeability and calcification. Proc Biol Sci (2011) 1.91
Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. J Psychiatry Neurosci (2012) 1.88
Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J Neurosci (2011) 1.82
[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease. Brain (2003) 1.70
Resolution modeling in PET imaging: theory, practice, benefits, and pitfalls. Med Phys (2013) 1.69
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain (2004) 1.65
Aberrant localization of synchronous hemodynamic activity in auditory cortex reliably characterizes schizophrenia. Biol Psychiatry (2004) 1.65
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord (2009) 1.64
Irrational choice under uncertainty correlates with lower striatal D(2/3) receptor binding in rats. J Neurosci (2012) 1.57
Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry (2010) 1.57
Neural primacy of the salience processing system in schizophrenia. Neuron (2013) 1.50
Statistical dynamic image reconstruction in state-of-the-art high-resolution PET. Phys Med Biol (2005) 1.50
Oxcarbazepine in the treatment of bipolar disorder: a review. Can J Psychiatry (2006) 1.50
Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers. Neurology (2013) 1.50
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression. Br J Psychiatry (2010) 1.45
Clinical guidelines for depressive disorders. Summary of recommendations relevant to family physicians. Can Fam Physician (2003) 1.45
Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med (2005) 1.42
Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis? J Psychiatry Neurosci (2006) 1.41
Aberrant salience network (bilateral insula and anterior cingulate cortex) connectivity during information processing in schizophrenia. Schizophr Res (2010) 1.39
Do the symptoms of bipolar disorder really show seasonal variation? Bipolar Disord (2013) 1.39
NEMA NU 4-2008 comparison of preclinical PET imaging systems. J Nucl Med (2012) 1.38
Recovery and recurrence following a first episode of mania: a systematic review and meta-analysis of prospectively characterized cohorts. J Clin Psychiatry (2015) 1.38
Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res (2002) 1.36
In vivo light-microscopic documentation for primary calcification processes in the hermatypic coral Stylophora pistillata. Cell Tissue Res (2006) 1.36
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord (2009) 1.34
Reproducibility of the hemodynamic response to auditory oddball stimuli: a six-week test-retest study. Hum Brain Mapp (2003) 1.31
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol (2008) 1.30
Accurate event-driven motion compensation in high-resolution PET incorporating scattered and random events. IEEE Trans Med Imaging (2008) 1.29
Effects of motivation and medication on electrophysiological markers of response inhibition in children with attention-deficit/hyperactivity disorder. Biol Psychiatry (2009) 1.28
Toward [18F]-labeled aryltrifluoroborate radiotracers: in vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in mice. J Am Chem Soc (2008) 1.28
Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. J Psychiatry Neurosci (2006) 1.28
Attention orienting dysfunction during salient novel stimulus processing in schizophrenia. Schizophr Res (2005) 1.27
Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother (2009) 1.26
The role of seawater endocytosis in the biomineralization process in calcareous foraminifera. Proc Natl Acad Sci U S A (2009) 1.24
Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia. Brain (2003) 1.24
Arylfluoroborates and alkylfluorosilicates as potential PET imaging agents: high-yielding aqueous biomolecular 18F-labeling. J Am Chem Soc (2005) 1.23
Error-related negativity and correct response negativity in schizophrenia. Clin Neurophysiol (2002) 1.22
Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease. Brain (2011) 1.20
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease. Ann Neurol (2011) 1.19
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord (2009) 1.17
Changes in brain network activity during working memory tasks: a magnetoencephalography study. Neuroimage (2010) 1.15
Aberrant cortical gyrification in schizophrenia: a surface-based morphometry study. J Psychiatry Neurosci (2012) 1.15
Technical performance evaluation of a human brain PET/MRI system. Eur Radiol (2012) 1.14
The influence of working memory load on phase specific patterns of cortical activity. Brain Res Cogn Brain Res (2004) 1.14
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial. Depress Anxiety (2010) 1.14
Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. J Clin Psychiatry (2008) 1.14
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. J Affect Disord (2009) 1.14
Structural correlates of auditory hallucinations in schizophrenia: a meta-analysis. Schizophr Res (2012) 1.13
Temporal lobe abnormalities in semantic processing by criminal psychopaths as revealed by functional magnetic resonance imaging. Psychiatry Res (2004) 1.13
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord (2009) 1.12
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry (2013) 1.12
Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes (2005) 1.11
Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival. Nat Med (2006) 1.10
Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother (2008) 1.09
Bipolar disorder and quality of life: a patient-centered perspective. Qual Life Res (2006) 1.08
Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol (2007) 1.07
The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biol Psychiatry (2004) 1.07
Cyclotron production of (99m)Tc: experimental measurement of the (100)Mo(p,x)(99)Mo, (99m)Tc and (99g)Tc excitation functions from 8 to 18 MeV. Nucl Med Biol (2011) 1.07
Manganese-52 positron emission tomography tracer characterization and initial results in phantoms and in vivo. Med Phys (2013) 1.07
Substituent effects on aryltrifluoroborate solvolysis in water: implications for Suzuki-Miyaura coupling and the design of stable (18)F-labeled aryltrifluoroborates for use in PET imaging. J Org Chem (2008) 1.06
The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. Curr Pharm Des (2012) 1.05
Cortical gray matter in attention-deficit/hyperactivity disorder: a structural magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry (2010) 1.05
PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium. Am J Psychiatry (2002) 1.03
State dependent changes in error monitoring in schizophrenia. J Psychiatr Res (2004) 1.03
Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord (2012) 1.02
Differential effects of surface area, gyrification and cortical thickness on voxel based morphometric deficits in schizophrenia. Neuroimage (2011) 1.02
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET. Synapse (2003) 1.02
Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Mov Disord (2010) 1.01
Folding of the prefrontal cortex in schizophrenia: regional differences in gyrification. Biol Psychiatry (2011) 1.00
Brain potentials implicate temporal lobe abnormalities in criminal psychopaths. J Abnorm Psychol (2006) 1.00
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin. Clin Cancer Res (2008) 0.99
A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis. Neuropsychopharmacology (2006) 0.99
Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism. J Cereb Blood Flow Metab (2011) 0.99
Looking before you leap: a theory of motivated control of action. Cognition (2009) 0.99
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Arch Neurol (2004) 0.98
A supramodal limbic-paralimbic-neocortical network supports goal-directed stimulus processing. Hum Brain Mapp (2005) 0.98